AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

出版年份 2008 全文链接

标题

作者

关键词

出版物

Volume 7, Issue 9, Pages 2955-2966

出版商

American Association for Cancer Research (AACR)

发表日期

2008-09-12

DOI

10.1158/1535-7163.mct-08-0492

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now